Prevention Of Recurrence Of Atrial Fibrillation

Clinical trial NCT00041496 · COMPLETED

Trial details

NCT number: NCT00041496
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Fibrillation, Atrial

Start date: 2001-11-01
Primary completion: 2003-12-01
Enrollment: 520

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.